Imaging of dopamine transporters: Biomarker for progression in Parkinson's disease

被引：0
|
作者：
Innis, RB [1 ]
Seibyl, J
Marek, K
机构：
[1] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA
[3] Yale Univ, Sch Med, Dept Neurol & Diagnost Radiol, New Haven, CT 06510 USA
来源：
CNS DRUG REVIEWS | 2000年 / 6卷
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：33 / 33
页数：1
相关论文
共 50 条
  • [1] Imaging dopamine transporters in Parkinson's disease
    Brooks, David J.
    BIOMARKERS IN MEDICINE, 2010, 4 (05) : 651 - 660
  • [2] Dopamine Transporter Imaging as Monitoring Biomarker in Parkinson's disease (PD)
    van Eimeren, T.
    Dzialas, V.
    Bischof, G.
    Moellenhoff, K.
    Drzezga, A.
    MOVEMENT DISORDERS, 2024, 39 : S476 - S476
  • [3] Dopamine Transporter Imaging as Objective Monitoring Biomarker in Parkinson's Disease
    Dzialas, Verena
    Bischof, Gerard N.
    Moellenhoff, Kathrin
    Drzezga, Alexander
    van Eimeren, Thilo
    ANNALS OF NEUROLOGY, 2025,
  • [4] Substantia Nigra Neuromelanin as an Imaging Biomarker of Disease Progression in Parkinson's Disease
    Fabbri, Margherita
    Reimao, Sofia
    Carvalho, Miguel
    Nunes, Rita G.
    Abreu, Daisy
    Guedes, Leonor Correia
    Bouca, Raquel
    Lobo, Patricia P.
    Godinho, Catarina
    Coelho, Miguel
    Goncalves, Nilza C.
    Rosa, Mario Miguel
    Antonini, Angelo
    Ferreira, Joaquim J.
    JOURNAL OF PARKINSONS DISEASE, 2017, 7 (03) : 491 - 501
  • [5] Imaging biomarker for progression of motor symptoms in advanced Parkinson's disease
    Furukawa, K.
    Sawamoto, N.
    Shima, A.
    Kambe, D.
    Nishida, A.
    Wada, I.
    Sakamaki, H.
    Yoshimura, K.
    Fushimi, Y.
    Okada, T.
    Togashi, K.
    Takahashi, R.
    MOVEMENT DISORDERS, 2019, 34 : S789 - S789
  • [6] 1231 β-CIT and SPECT:: An imaging biomarker of Parkinson's disease progression
    Marek, K
    Innis, R
    Fussell, B
    Smith, E
    van Dyck, C
    Seibyl, J
    NEUROLOGY, 1998, 50 (04) : A329 - A329
  • [7] Qalb as a biomarker of Parkinson's disease progression
    Boika, A.
    Ponomarev, V.
    Mazurenka, K.
    Chyzhyk, V.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 625 - 625
  • [8] Imaging of dopamine transporters with iodine-123-beta-CIT and SPECT in Parkinson's disease
    Asenbaum, S
    Brucke, T
    Pirker, W
    Podreka, I
    Angelberger, P
    Wenger, S
    Wober, C
    Muller, C
    Deecke, L
    JOURNAL OF NUCLEAR MEDICINE, 1997, 38 (01) : 1 - 6
  • [9] Striatal dopamine transporters and cognitive function in Parkinson's disease
    Stoegbauer, Jakob
    Rosar, Florian
    Dillmann, Ulrich
    Fassbender, Klaus
    Ezziddin, Samer
    Spiegel, Joerg
    ACTA NEUROLOGICA SCANDINAVICA, 2020, 142 (04): : 385 - 391
  • [10] Parkinson's Disease: Caffeine Intake influences Dopamine Transporters
    不详
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2025, 93 (03) : 75 - 76
12345